SCHEMBL7512121

SCHEMBL7512121

O=[C]C(S)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.45
▸ EPHX1 P07099 2/20 0.44
▸ CPA3 P15088 1/20 0.44
▸ FOLH1 Q04609 1/20 0.44
▸ ANPEP P15144 2/20 0.43
▸ ALPI P09923 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ XIAP P98170 1/20 0.42
▸ SLC7A5 Q01650 1/20 0.42
▸ MME P08473 2/20 0.42
▸ SLC6A2 P23975 2/20 0.41
▸ TAAR1 Q96RJ0 2/20 0.41
▸ MAOA P21397 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ADORA1 P30542 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8696247 0.78 GFER (0.41) ANPEPMAOA
SCHEMBL12435541 0.77 MAOB (0.47) CYP1A2EPHX1ANPEPPKMSLC6A2
SCHEMBL10940258 0.77 EPHX1 (0.44) CYP1A2EPHX1CPA3ANPEPMME
SCHEMBL22798139 0.76 CYP1A2 (0.48) CYP1A2EPHX1CPA3FOLH1ANPEP
SCHEMBL1697450 0.76 CYP1A2 (0.48) CYP1A2EPHX1CPA3FOLH1ANPEP
SCHEMBL27758693 0.74 CYP1A2 (0.46) CYP1A2EPHX1CPA3FOLH1ANPEP
SCHEMBL28108544 0.74 FOLH1 (0.50) CYP1A2EPHX1CPA3FOLH1ANPEP
SCHEMBL28422388 0.74 TAAR1 (0.43) CYP1A2EPHX1ANPEPSLC6A2TAAR1
SCHEMBL5561126 0.73 CYP1A2 (0.50) CYP1A2EPHX1CPA3FOLH1ANPEP
SCHEMBL97558 0.73 TAAR1 (0.52) CYP1A2EPHX1SLC6A2TAAR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0187956-A2 Pharmaceutical composition for the treatment of defects of the gastrointestinal mucous membrane BOEHRINGER INGELHEIM KG (DE) 1986-07-23 — — EP claimed
EP-1051419-A4 DEPROTECTION AND RECRYSTALLIZATION PROCESSES BRISTOL MYERS SQUIBB CO (US) 2002-08-28 — — EP disclosed
EP-1051419-A1 DEPROTECTION AND RECRYSTALLIZATION PROCESSES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-11-15 — — EP disclosed
WO-1999035145-A1 DEPROTECTION AND RECRYSTALLIZATION PROCESSES BRISTOL-MYERS SQUIBB COMPANY (US) 1999-07-15 — — WO disclosed
EP-0187956-A2 Pharmaceutical composition for the treatment of defects of the gastrointestinal mucous membrane BOEHRINGER INGELHEIM KG (DE) 1986-07-23 — — EP disclosed
US-3969412-A 16,17-Seco-delta 4,9(10) and -delta 4,9(10),11 steroids SYNTEX (U.S.A.) INC. (US) 1976-07-13 — — US disclosed
Send feedback